FDA Inspection
Diagnostic Grifols, S.A.Diagnostic Grifols, S.A. – FDA Inspection, Nov 14, 2016
Record Details
This FDA Inspection record concerns Diagnostic Grifols, S.A., with an inspection on November 14, 2016, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · dd9b5ada-6b05-41bf-9251-2b32a99ff4fc
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1004513
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
Other FDA inspections of Diagnostic Grifols, S.A.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| May 9, 2025 | Not classified | Office of Inspections and Investigations | |
| December 14, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 20, 2017 | Not classified | Office of Inspections and Investigations | |
| February 16, 2017 | VAI | Center for Devices and Radiological Health | Compliance: Devices |
| January 30, 2015 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Diagnostic Grifols, S.A.
- FDA Inspection 1273855 - 2025-05-09
- FDA Inspection 1082479 - 2018-12-14
- FDA Inspection 1031526 - 2017-07-20
- FDA Inspection 1002584 - 2017-02-16
- FDA Inspection 919194 - 2015-01-30
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.